The genetics of melanoma: The UK experience

Clinical and Experimental Dermatology

Volumn 23, Issue 4, 1998, Pages 158-161

  Newton Bishop, J A ^a   Harland, M ^a   Bishop, D T ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHROMOSOME 9; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MELANOMA; MULTIGENE FAMILY; PATIENT COUNSELING; PEDIGREE; PRIORITY JOURNAL; UNITED KINGDOM;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; NEOPLASTIC SYNDROMES, HEREDITARY; PEDIGREE; SKIN NEOPLASMS;

EID: 0031769236     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1998.00344.x     Document Type: Article

References (23)

1. Armstrong B. Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun? J Dermatol Surg Oncol 1988; 14: 835-49.
2. Traboulsi EI, Zimmerman LE, Manz HJ. Cutaneous malignant melanoma in survivors of heritable retinoblastoma. Arch Ophthalmol 1988; 106: 1059-61.
3. Hall NR, Williams MA, Murday VA, et al. Muir-Torre syndrome: a variant of the cancer family syndrome. J Med Genet 1994; 31: 627-31.
4. Schwartz RA, Torre DP. The Muir-Torre syndrome: a 25 year retrospect. J Am Acad Dermatol 1995; 33: 90-104.
5. Newton Bishop J, Bataille V, Pinney E, Bishop D. Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotype. Mel Res 1994; 4: 199-206.
6. Newton JA. Familial melanoma. Clin Exp Dermatol 1993; 18: 5-11.
7. Bergman W, Palan A, Went LN. Clinical and genetic studies in six Dutch kindreds with the dysplastic naevus syndrome. Ann Hum Genet 1986; 50: 249-58.
8. Friedmann T. Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer 1992; 70: 1810-7.
9. Hale SJ, Dracopoli NC, Tucker MA et al. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic naevus to chromosome 1. New Engl J Med 1989; 320: 1367-72.
10. Gruis NA, Bergman W, Frants RR. Locus for susceptibility to melanoma on chromosome 1p. New Engl J Med 1990; 322: 853-4.
11. Cannon-Albright LA, Goldgar DE, Wright EC et al. Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome 1p36. Am J Hum Genet 1990; 46: 912-8.
12. Nancarrow DJ, Palmer JM, Walters MK et al. Exclusion of the familial melanoma locus (MLM) from the PND/D1S47 and MYCL1 regions of chromosomes arm 1p in 7 Australian pedigrees. Genomics 1992; 12: 18-25.
13. Cannon-Albright L, Goldgar D, Meyer L et al. Assignment of a locus for familial melanoma MLM, to chromosome 9P13-22. Science 1992; 258: 1148-52.
14. Nancarro D, Mann G, Holland K et al. Confirmation of chromosome 9p linkage in familial melanoma. Am J Hum Genet 1993; 53: 936-42.
15. MacGeoch C, Newton Bishop J, Bataille V et al. Genetic heterogeneity in familial malignant melanoma. Hum Mol Genet 1994; 3: 2195-200.
16. Kamb A, Gruis N, Weaver-Feldhaus J et al. A cell cycle regulator potentially involved in genesis of many tumour types. Science 1994; 264: 436-40.
17. Gruis N, Sandkuijl L, van der Velden P et al. CDKN2 explains part of the clinical phenotype in Dutch familial multiple-mole melanoma (FAMMM) syndrome families. Mel Res 1995; 5: 169-77.
18. Liu L, Lassam N, Singerland J et al. Germline p161NK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene 1995; 11: 405-12.
19. Lilischkis R, Sarcevic B, Kennedy C, et al. Cancer associated missense and deletion mutations impair p161NK4 CDK inhibitory activity. Int J Cancer 1996; 66: 249-54.
20. Zuo L, Weger J, Yang Q et al. Germline mutations in the p161NK4a binding domain of CDK4 in familial melanoma. Nature Genet 1996; 12: 97-9.
21. Harland M, Meloni R, Gruis N et al. Germline mutations of the CDKN2 gene in UK melanoma families. Hum Molec Genet 1997; 6: 2061-7.
22. Dracopoli N, Fountain J. CDKN2 mutations in melanoma. Cancer Surveys 1996; 26: 115-32.
23. Fitzgerald M, Harkin D, Silva-Arrieta S et al. Prevalence of germ-line mutations in p16 and VDK4 in familial melanoma: analysis of a clinic based population. Proc Natl Acad Sci, USA 1996; 93: 8541-5.